MGC Pharmaceuticals Limited Director/PDMR Shareholding (3970Z)
January 11 2024 - 3:54AM
UK Regulatory
TIDMMXC
RNS Number : 3970Z
MGC Pharmaceuticals Limited
11 January 2024
MGC Pharmaceuticals Ltd.
PDMR Notification
11 January 2024
ASX, LSE: MXC
MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') wishes
to advise that the following Persons Discharging Managerial
Responsibilities (PDMR) have dealt with shares in MGC Pharma, and
this notification is made in accordance the UK Market Abuse
Regulations.
The shares subject of this notice were issued to the PDMR's as
part of their working contracts and as consideration for services
rendered in lieu of cash payments
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Amir Polak
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Chief Pharmaceutical Development
Officer
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- ---------------- ------------------------
AUD A$0.55 600,000 A$330,000
----------------- --------------------- ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 600,000 A$330,000
----------------- --------------------- ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Sabina Suljakovic
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Vice President of Global Quality
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- ---------------- ------------------------
AUD A$0.55 17,000 A$9,350
----------------- --------------------- ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 17,000 A$9,350
----------------- --------------------- ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Yair Tal
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Chief Information Security Officer
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
----------------- --------------------- ---------------- ------------------------
AUD A$0.55 300,000 A$165,000
----------------- --------------------- ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 300,000 A$165,000
----------------- --------------------- ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Yifat Steuer
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Chief Operating Officer and Deputy
CEO
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
-------------------- ------------------ ---------------- ------------------------
AUD A$0.55 1,100,000 A$605,000
-------------------- ------------------ ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 1,100,000 A$605,000
-------------------- ------------------ ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Rowan Harland
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Company Secretary
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
-------------------- ------------------ ---------------- ------------------------
AUD A$0.55 7,000 A$3,850
-------------------- ------------------ ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 7,000 A$3,850
-------------------- ------------------ ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Ana Arhar Oblak
-------------------------------------- --------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------
(a) Position Group Financial Controller
-------------------------------------- --------------------------------------------
(b) Initial notification/amendment Initial
-------------------------------------- --------------------------------------------
(c) If amendment: reason n/a
-------------------------------------- --------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
-------------------------------------- --------------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
-------------------------------------- --------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
-------------------------------------- --------------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
-------------------------------------- --------------------------------------------
(c) Nature of transaction Shares issued as part of their
working contracts and as consideration
for services rendered in lieu
of cash payments
-------------------------------------- --------------------------------------------
(d) Currency Price Volume Total
-------------------- ------------------ ---------------- ------------------------
AUD A$0.55 10,000 A$5,500
-------------------- ------------------ ---------------- ------------------------
Aggregated information
------------------------------------------------------------------------------------
AUD A$0.55 10,000 A$5,500
-------------------- ------------------ ---------------- ------------------------
(e) Date of transaction 10 January 2024
-------------------------------------- --------------------------------------------
(f) Place of transaction Outside a trading venue
-------------------------------------- --------------------------------------------
-Ends-
Authorised for release by the Managing Director, for further
information please contact:
MGC Pharmaceuticals Ltd MGC Pharmaceuticals Ltd
Roby Zomer Rowan Harland
CEO & Managing Director Company Secretary
+61 8 6555 2950 +61 8 6555 2950
info@mgcpharma.co.uk info@mgcpharma.co.uk
UK IR/PR Advisers UK Brokers
IFC Advisory Oberon Capital
Graham Herring / Tim Metcalfe / Aimee McCusker / Adam Pollock
Zach Cohen +44 203 179 5300
+44 203 934 6630 aimeemccusker@oberoninvestments.com
mgcpharma@investor-focus.co.uk adampollock@oberoninvestments.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHKFLBFZFLEBBL
(END) Dow Jones Newswires
January 11, 2024 04:54 ET (09:54 GMT)
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
From Apr 2023 to Apr 2024
